Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1998 Dec;44:2709–2717.

Coronary artery disease in women.

V Chiamvimonvat 1, L Sternberg 1
PMCID: PMC2277786  PMID: 9870124

Abstract

OBJECTIVE: To review and recognize how presentation, investigation, risk factor modification, and treatment of coronary artery disease (CAD) is different for women than for men. QUALITY OF EVIDENCE: Epidemiologic data are from well-recognized, peer-reviewed medical journals. Most data on treatment are from randomized controlled trials. MAIN FINDINGS: Coronary artery disease is the leading cause of mortality in women, with incidence after menopause equal to that of men. Diabetes and postmenopausal status without hormone replacement therapy are the strongest risk factors. Women with CAD are more likely to have atypical symptoms, including nonexertional chest pain; pain in other locations, such as jaw, arms, shoulder, back, and epigastrium; and angina-equivalents, such as dyspnea, palpitations, and presyncope. Because women have atypical symptoms, physicians should maintain a high level of suspicion. Although newer nonivasive stress imaging modalities provide greater diagnostic accuracy than traditional exercise stress testing, the tests are still less accurate for women. A safe and cost-effective approach to investigation can be guided by clinical likelihood for CAD based on patients' age, chest pain quality, and risk factors. Treatment and preventive strategies are generally similar for women and men. CONCLUSION: Coronary artery disease is a serious cause of morbidity and mortality in women and will continue to gain importance as women's life expectancy increases. Important differences in presentation, risk factors, investigation, and treatment of women exist and should be recognized.

Full text

PDF
2709

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ades P. A., Waldmann M. L., McCann W. J., Weaver S. O. Predictors of cardiac rehabilitation participation in older coronary patients. Arch Intern Med. 1992 May;152(5):1033–1035. [PubMed] [Google Scholar]
  2. Ades P. A., Waldmann M. L., Polk D. M., Coflesky J. T. Referral patterns and exercise response in the rehabilitation of female coronary patients aged greater than or equal to 62 years. Am J Cardiol. 1992 Jun 1;69(17):1422–1425. doi: 10.1016/0002-9149(92)90894-5. [DOI] [PubMed] [Google Scholar]
  3. Barrett-Connor E., Bush T. L. Estrogen and coronary heart disease in women. JAMA. 1991 Apr 10;265(14):1861–1867. [PubMed] [Google Scholar]
  4. Barrett-Connor E., Wingard D. L. Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study. Am J Epidemiol. 1983 Oct;118(4):489–496. doi: 10.1093/oxfordjournals.aje.a113654. [DOI] [PubMed] [Google Scholar]
  5. Brown K. A. Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age. Circulation. 1991 Feb;83(2):363–381. doi: 10.1161/01.cir.83.2.363. [DOI] [PubMed] [Google Scholar]
  6. Cannistra L. B., Balady G. J., O'Malley C. J., Weiner D. A., Ryan T. J. Comparison of the clinical profile and outcome of women and men in cardiac rehabilitation. Am J Cardiol. 1992 May 15;69(16):1274–1279. doi: 10.1016/0002-9149(92)91220-x. [DOI] [PubMed] [Google Scholar]
  7. Cerqueira M. D. Diagnostic testing strategies for coronary artery disease: special issues related to gender. Am J Cardiol. 1995 Apr 13;75(11):52D–60D. [PubMed] [Google Scholar]
  8. Colditz G. A., Willett W. C., Stampfer M. J., Rosner B., Speizer F. E., Hennekens C. H. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987 Apr 30;316(18):1105–1110. doi: 10.1056/NEJM198704303161801. [DOI] [PubMed] [Google Scholar]
  9. Collins R., Peto R., MacMahon S., Hebert P., Fiebach N. H., Eberlein K. A., Godwin J., Qizilbash N., Taylor J. O., Hennekens C. H. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990 Apr 7;335(8693):827–838. doi: 10.1016/0140-6736(90)90944-z. [DOI] [PubMed] [Google Scholar]
  10. Cornoni-Huntley J., LaCroix A. Z., Havlik R. J. Race and sex differentials in the impact of hypertension in the United States. The National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Intern Med. 1989 Apr;149(4):780–788. [PubMed] [Google Scholar]
  11. Davis K. B., Chaitman B., Ryan T., Bittner V., Kennedy J. W. Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease: a CASS registry study. Coronary Artery Surgery Study. J Am Coll Cardiol. 1995 Apr;25(5):1000–1009. doi: 10.1016/0735-1097(94)00518-u. [DOI] [PubMed] [Google Scholar]
  12. Diamond G. A., Forrester J. S. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med. 1979 Jun 14;300(24):1350–1358. doi: 10.1056/NEJM197906143002402. [DOI] [PubMed] [Google Scholar]
  13. Douglas P. S., Ginsburg G. S. The evaluation of chest pain in women. N Engl J Med. 1996 May 16;334(20):1311–1315. doi: 10.1056/NEJM199605163342007. [DOI] [PubMed] [Google Scholar]
  14. Eaker E. D., Packard B., Wenger N. K., Clarkson T. B., Tyroler H. A. Coronary artery disease in women. Am J Cardiol. 1988 Mar 1;61(8):641–644. doi: 10.1016/0002-9149(88)90781-3. [DOI] [PubMed] [Google Scholar]
  15. Fisher L. D., Kennedy J. W., Davis K. B., Maynard C., Fritz J. K., Kaiser G., Myers W. O. Association of sex, physical size, and operative mortality after coronary artery bypass in the Coronary Artery Surgery Study (CASS). J Thorac Cardiovasc Surg. 1982 Sep;84(3):334–341. [PubMed] [Google Scholar]
  16. Folsom A. R., Kaye S. A., Sellers T. A., Hong C. P., Cerhan J. R., Potter J. D., Prineas R. J. Body fat distribution and 5-year risk of death in older women. JAMA. 1993 Jan 27;269(4):483–487. [PubMed] [Google Scholar]
  17. Friedman T. D., Greene A. C., Iskandrian A. S., Hakki A. H., Kane S. A., Segal B. L. Exercise thallium-201 myocardial scintigraphy in women: correlation with coronary arteriography. Am J Cardiol. 1982 May;49(7):1632–1637. doi: 10.1016/0002-9149(82)90239-9. [DOI] [PubMed] [Google Scholar]
  18. Gitler B., Fishbach M., Steingart R. M. Use of electrocardiographic-thallium exercise testing in clinical practice. J Am Coll Cardiol. 1984 Feb;3(2 Pt 1):262–271. doi: 10.1016/s0735-1097(84)80009-1. [DOI] [PubMed] [Google Scholar]
  19. Grady D., Rubin S. M., Petitti D. B., Fox C. S., Black D., Ettinger B., Ernster V. L., Cummings S. R. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992 Dec 15;117(12):1016–1037. doi: 10.7326/0003-4819-117-12-1016. [DOI] [PubMed] [Google Scholar]
  20. Grodstein F., Stampfer M. J., Manson J. E., Colditz G. A., Willett W. C., Rosner B., Speizer F. E., Hennekens C. H. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med. 1996 Aug 15;335(7):453–461. doi: 10.1056/NEJM199608153350701. [DOI] [PubMed] [Google Scholar]
  21. Gueyffier F., Boutitie F., Boissel J. P., Pocock S., Coope J., Cutler J., Ekbom T., Fagard R., Friedman L., Perry M. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators. Ann Intern Med. 1997 May 15;126(10):761–767. doi: 10.7326/0003-4819-126-10-199705150-00002. [DOI] [PubMed] [Google Scholar]
  22. Hachamovitch R., Berman D. S., Kiat H., Bairey-Merz N., Cohen I., Cabico J. A., Friedman J. D., Germano G., Van Train K. F., Diamond G. A. Gender-related differences in clinical management after exercise nuclear testing. J Am Coll Cardiol. 1995 Nov 15;26(6):1457–1464. doi: 10.1016/0735-1097(95)00356-8. [DOI] [PubMed] [Google Scholar]
  23. Hennekens C. H., Albert C. M., Godfried S. L., Gaziano J. M., Buring J. E. Adjunctive drug therapy of acute myocardial infarction--evidence from clinical trials. N Engl J Med. 1996 Nov 28;335(22):1660–1667. doi: 10.1056/NEJM199611283352207. [DOI] [PubMed] [Google Scholar]
  24. Holdright D. R., Fox K. M. Characterization and identification of women with angina pectoris. Eur Heart J. 1996 Apr;17(4):510–517. doi: 10.1093/oxfordjournals.eurheartj.a014902. [DOI] [PubMed] [Google Scholar]
  25. Iliceto S., Galiuto L., Marangelli V., Rizzon P. Clinical use of stress echocardiography: factors affecting diagnostic accuracy. Eur Heart J. 1994 May;15(5):672–680. doi: 10.1093/oxfordjournals.eurheartj.a060566. [DOI] [PubMed] [Google Scholar]
  26. Jacobs A. K., Kelsey S. F., Yeh W., Holmes D. R., Jr, Block P. C., Cowley M. J., Bourassa M. G., Williams D. O., King S. B., 3rd, Faxon D. P. Documentation of decline in morbidity in women undergoing coronary angioplasty (a report from the 1993-94 NHLBI Percutaneous Transluminal Coronary Angioplasty Registry). National Heart, Lung, and Blood Institute. Am J Cardiol. 1997 Oct 15;80(8):979–984. doi: 10.1016/s0002-9149(97)00588-2. [DOI] [PubMed] [Google Scholar]
  27. Jong P., Mohammed S., Sternberg L. Sex differences in the features of coronary artery disease of patients undergoing coronary angiography. Can J Cardiol. 1996 Jul;12(7):671–677. [PubMed] [Google Scholar]
  28. Kannel W. B., McGee D. L. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979 May 11;241(19):2035–2038. doi: 10.1001/jama.241.19.2035. [DOI] [PubMed] [Google Scholar]
  29. Kelsey S. F., James M., Holubkov A. L., Holubkov R., Cowley M. J., Detre K. M. Results of percutaneous transluminal coronary angioplasty in women. 1985-1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry. Circulation. 1993 Mar;87(3):720–727. doi: 10.1161/01.cir.87.3.720. [DOI] [PubMed] [Google Scholar]
  30. Krivokapich J., Child J. S., Gerber R. S., Lem V., Moser D. Prognostic usefulness of positive or negative exercise stress echocardiography for predicting coronary events in ensuing twelve months. Am J Cardiol. 1993 Mar 15;71(8):646–651. doi: 10.1016/0002-9149(93)91004-2. [DOI] [PubMed] [Google Scholar]
  31. Lerner D. J., Kannel W. B. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986 Feb;111(2):383–390. doi: 10.1016/0002-8703(86)90155-9. [DOI] [PubMed] [Google Scholar]
  32. Lusiani L., Perrone A., Pesavento R., Conte G. Prevalence, clinical features, and acute course of atypical myocardial infarction. Angiology. 1994 Jan;45(1):49–55. doi: 10.1177/000331979404500107. [DOI] [PubMed] [Google Scholar]
  33. Manglos S. H., Thomas F. D., Gagne G. M., Hellwig B. J. Phantom study of breast tissue attenuation in myocardial imaging. J Nucl Med. 1993 Jun;34(6):992–996. [PubMed] [Google Scholar]
  34. Manson J. E., Colditz G. A., Stampfer M. J., Willett W. C., Krolewski A. S., Rosner B., Arky R. A., Speizer F. E., Hennekens C. H. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med. 1991 Jun;151(6):1141–1147. [PubMed] [Google Scholar]
  35. Manson J. E., Lee I. M. Exercise for women--how much pain for optimal gain? N Engl J Med. 1996 May 16;334(20):1325–1327. doi: 10.1056/NEJM199605163342010. [DOI] [PubMed] [Google Scholar]
  36. Marcovitz P. A., Armstrong W. F. Accuracy of dobutamine stress echocardiography in detecting coronary artery disease. Am J Cardiol. 1992 May 15;69(16):1269–1273. doi: 10.1016/0002-9149(92)91219-t. [DOI] [PubMed] [Google Scholar]
  37. Moore S. M. Women's views of cardiac rehabilitation programs. J Cardiopulm Rehabil. 1996 Mar-Apr;16(2):123–129. doi: 10.1097/00008483-199603000-00007. [DOI] [PubMed] [Google Scholar]
  38. Mosca L., Manson J. E., Sutherland S. E., Langer R. D., Manolio T., Barrett-Connor E. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group. Circulation. 1997 Oct 7;96(7):2468–2482. doi: 10.1161/01.cir.96.7.2468. [DOI] [PubMed] [Google Scholar]
  39. Oldridge N. B., Guyatt G. H., Fischer M. E., Rimm A. A. Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials. JAMA. 1988 Aug 19;260(7):945–950. [PubMed] [Google Scholar]
  40. Pepine C. J., Abrams J., Marks R. G., Morris J. J., Scheidt S. S., Handberg E. Characteristics of a contemporary population with angina pectoris. TIDES Investigators. Am J Cardiol. 1994 Aug 1;74(3):226–231. doi: 10.1016/0002-9149(94)90361-1. [DOI] [PubMed] [Google Scholar]
  41. Pfeffer M. A., Braunwald E., Moyé L. A., Basta L., Brown E. J., Jr, Cuddy T. E., Davis B. R., Geltman E. M., Goldman S., Flaker G. C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992 Sep 3;327(10):669–677. doi: 10.1056/NEJM199209033271001. [DOI] [PubMed] [Google Scholar]
  42. Pilote L., Hlatky M. A. Attitudes of women toward hormone therapy and prevention of heart disease. Am Heart J. 1995 Jun;129(6):1237–1238. doi: 10.1016/0002-8703(95)90426-3. [DOI] [PubMed] [Google Scholar]
  43. Reunanen A., Suhonen O., Aromaa A., Knekt P., Pyörälä K. Incidence of different manifestations of coronary heart disease in middle-aged Finnish men and women. Acta Med Scand. 1985;218(1):19–26. doi: 10.1111/j.0954-6820.1985.tb08819.x. [DOI] [PubMed] [Google Scholar]
  44. Rich-Edwards J. W., Manson J. E., Hennekens C. H., Buring J. E. The primary prevention of coronary heart disease in women. N Engl J Med. 1995 Jun 29;332(26):1758–1766. doi: 10.1056/NEJM199506293322607. [DOI] [PubMed] [Google Scholar]
  45. Sacks F. M., Pfeffer M. A., Moye L. A., Rouleau J. L., Rutherford J. D., Cole T. G., Brown L., Warnica J. W., Arnold J. M., Wun C. C. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996 Oct 3;335(14):1001–1009. doi: 10.1056/NEJM199610033351401. [DOI] [PubMed] [Google Scholar]
  46. Sempos C. T., Cleeman J. I., Carroll M. D., Johnson C. L., Bachorik P. S., Gordon D. J., Burt V. L., Briefel R. R., Brown C. D., Lippel K. Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel. JAMA. 1993 Jun 16;269(23):3009–3014. doi: 10.1001/jama.269.23.3009. [DOI] [PubMed] [Google Scholar]
  47. Shaw L. J., Hachamovitch R., Iskandrian A. E. Treadmill test scores: attributes and limitations. J Nucl Cardiol. 1997 Jan-Feb;4(1 Pt 1):74–78. doi: 10.1016/s1071-3581(97)90051-9. [DOI] [PubMed] [Google Scholar]
  48. Shepherd J., Cobbe S. M., Ford I., Isles C. G., Lorimer A. R., MacFarlane P. W., McKillop J. H., Packard C. J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995 Nov 16;333(20):1301–1307. doi: 10.1056/NEJM199511163332001. [DOI] [PubMed] [Google Scholar]
  49. Sketch M. H., Mohiuddin S. M., Lynch J. D., Zencka A. E., Runco V. Significant sex differences in the correlation of electrocardiographic exercise testing and coronary arteriograms. Am J Cardiol. 1975 Aug;36(2):169–173. doi: 10.1016/0002-9149(75)90521-4. [DOI] [PubMed] [Google Scholar]
  50. Stampfer M. J., Colditz G. A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991 Jan;20(1):47–63. doi: 10.1016/0091-7435(91)90006-p. [DOI] [PubMed] [Google Scholar]
  51. Sullivan A. K., Holdright D. R., Wright C. A., Sparrow J. L., Cunningham D., Fox K. M. Chest pain in women: clinical, investigative, and prognostic features. BMJ. 1994 Apr 2;308(6933):883–886. doi: 10.1136/bmj.308.6933.883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Taillefer R., DePuey E. G., Udelson J. E., Beller G. A., Latour Y., Reeves F. Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol. 1997 Jan;29(1):69–77. doi: 10.1016/s0735-1097(96)00435-4. [DOI] [PubMed] [Google Scholar]
  53. Vaccarino V., Krumholz H. M., Berkman L. F., Horwitz R. I. Sex differences in mortality after myocardial infarction. Is there evidence for an increased risk for women? Circulation. 1995 Mar 15;91(6):1861–1871. doi: 10.1161/01.cir.91.6.1861. [DOI] [PubMed] [Google Scholar]
  54. Wackers F. J., Russo D. J., Russo D., Clements J. P. Prognostic significance of normal quantitative planar thallium-201 stress scintigraphy in patients with chest pain. J Am Coll Cardiol. 1985 Jul;6(1):27–30. doi: 10.1016/s0735-1097(85)80247-3. [DOI] [PubMed] [Google Scholar]
  55. Weaver W. D., White H. D., Wilcox R. G., Aylward P. E., Morris D., Guerci A., Ohman E. M., Barbash G. I., Betriu A., Sadowski Z. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators. JAMA. 1996 Mar 13;275(10):777–782. [PubMed] [Google Scholar]
  56. Weiner D. A., Ryan T. J., McCabe C. H., Kennedy J. W., Schloss M., Tristani F., Chaitman B. R., Fisher L. D. Exercise stress testing. Correlations among history of angina, ST-segment response and prevalence of coronary-artery disease in the Coronary Artery Surgery Study (CASS). N Engl J Med. 1979 Aug 2;301(5):230–235. doi: 10.1056/NEJM197908023010502. [DOI] [PubMed] [Google Scholar]
  57. Willett W. C., Green A., Stampfer M. J., Speizer F. E., Colditz G. A., Rosner B., Monson R. R., Stason W., Hennekens C. H. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med. 1987 Nov 19;317(21):1303–1309. doi: 10.1056/NEJM198711193172102. [DOI] [PubMed] [Google Scholar]
  58. Yusuf S., Peto R., Lewis J., Collins R., Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985 Mar-Apr;27(5):335–371. doi: 10.1016/s0033-0620(85)80003-7. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES